Ir al contenido

Medyria has developed an innovative and unique prototype that significantly increases the effectiveness of tests to detect obstructive and non-obstructive coronary artery disease.

Medyria

Nombre Medyria
Estrategia Early Stage
Línea de Negocio Venture Capital
Estado Current Portfolio
Fundadores Mauro Sette
Sede Winterthur, Switzerland